IMMUNOABSORBER FOR USE IN SEPSIS THERAPY

• 1. 用于治疗自身免疫疾病的BLyS抑制和/或APRIL抑制与免疫抑制剂的组合 [P] . 中国专利： CN101678106B . 2013.06.05
• 2. 包含解离的糖皮质激素受体激动剂和免疫抑制剂的用于治疗干眼症的组合物 [P] . 中国专利： CN101484187B . 2012.12.26
• 3. IMMUNOABSORBER FOR USE IN SEPSIS THERAPY [P] . IL145557B . 2005-09-25

  机译： 用于脓毒症治疗的免疫抑制剂

• 4. IMMUNOABSORBER FOR USE IN SEPSIS THERAPY [P] . IL145557D0 . 2002-06-30

  机译： 用于脓毒症治疗的免疫抑制剂

• 5. METHOD AND SUBSTANCES FOR DIAGNOSIS AND THERAPY OF SEPSIS AND SEPSIS-LIKE SYSTEMIC INFECTIONS [P] . 欧洲知识产权局专利： EP1121600B2 . 2014-06-25

  机译： 诊断和治疗脓毒症和类似脓毒症的系统性感染的方法和物质

• 1. Dysfunction of neuroendocrine system in sepsis and implication of hormone therapy [J] . Qing-Hong Zhang, Yong-Ming Yao, Zhi-Yong Sheng 老年心脏病学杂志（英文版） . 2009,第004期
• 2. Blood Glucose and Sepsis Score on Sepsis Patients Requiring Insylin Therapy [C] . Fatanah Mohamad Suhaimi, Ummu Kulthum Jamaludin, Normy Norfiza Abdul Razak International Conference for Innovation in Biomedical Engineering and Life Sciences . 2018
• 3. Hyaluronic-acid based nanocarriers for RNAi therapy of advanced sepsis. [D] . Kosovrasti, Verbena Y. 2015
• 4. LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): Phase I/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock [O] . Faheem W Guirgis, Lauren Page Black, Martin Daniel Rosenthal, 2019
• 5. LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): Phase I/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock [O] . Faheem W Guirgis, Lauren Page Black, Martin Daniel Rosenthal, 2019

• 1. Research progress on anti-infection therapy for sepsis in children [J] . Guoxiu Lu . 国际感染杂志（电子版） . 2018,第002期
• 2. Research progress on anti-infection therapy for sepsis in children [J] . Guoxiu Lu . 国际感染杂志（电子版） . 2018,第002期
• 3. Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis? [J] . Dubravka Kojic ,Benedikt H Siegler ,Florian Uhle . 世界实验医学杂志 . 2015,第2期
• 4. The Utility of Procalcitonin as a Biomarker to Limit the Duration of Antibiotic Therapy in Adult Sepsis Patients [J] . Ronald S. Chamberlain ,Brian J. Shayota ,Carl Nyberg . 外科学（英文） . 2014,第8期
• 5. 脓毒症需要抗凝治疗吗?——对脓毒症抗凝治疗意义和方法的探讨 [C] . . 中华医学会2008年全国重症医学研讨会 . 2008
• 6. 新型免疫抑制剂应用于甲状腺相关性眼病的治疗 [A] . 曾琬舒 . 2014